Savings Effect

#Lupin launches Dapagliflozin & Metformin Hydrochloride extended-release tablets in the US

BETA DRUGS: IN THE PHILIPPINES, CO HAS RECEIVED CERTIFICATES OF PRODUCT REGISTRATION (CPR) FOR 2 BRANDS, BOTH OF WHICH ARE THE FIRST GENERIC APPROVALS IN THE MARKET. IT WILL PROVIDE THE CO. AN OPPORTUNITY TO ESTABLISH EARLY MARKET PRESENCE IN THESE PRODUCTS. CO EXPECTS FURTHER APPROVALS OVER NEXT 6 MONTHS

CRISIL: Guidance - Management stated that the company refrains from giving specific quantitative guidance on its future performance. - Concall Update CRISIL: Guidance - Forward-looking statements are based on current understanding of the company profile and market conditions, subject to change based on company policies and the macro environment. - Concall Update CRISIL: Guidance - The company does not commit to updating forward-looking statements or other information contained in the presentation. - Concall Update

BETA DRUGS LIMITED: CO HAS ACHIEVED IMPORTANT REGULATORY MILESTONES IN AZERBAIJAN AND THE PHILIPPINES, FURTHER ENHANCING ACCESS TO THE CIS AND SOUTHEAST ASIAN MARKETS AND STRENGTHENING THE COMPANY’S EXPORT SALES. CO EXPECTS TO RECEIVE GMP APPROVAL WITHIN THE NEXT ONE TO TWO MONTHS.

AMARA RAJA: CO PLANS TO BEGIN BULK PRODUCTION OF EV CELLS IN 2027 || AMARA RAJA HAS REVISED ITS CAPACITY ALLOCATION ACROSS THE PLANNED 16 GWH, MOVING FROM A LARGELY MOBILITY FOCUSED PLAN TO AN EQUAL SPLIT BETWEEN MOBILITY AND ENERGY STORAGE SOLUTIONS (ESS). - ET

GOVT'S AMMONIA RULE TO HURT DRUG FIRMS || PHARMA COS MAY FACE SHORTAGE OF THE KEY INPUT AS THE DIRECTIVE RESTRICTS SALE OF SURPLUS AMMONIA TO FERTILISER COS - ET

STOVEKRAFT: CO IS ENTERING ITS NEXT GROWTH PHASE DRIVEN BY ELECTRIC COOKING APPLIANCES (INDUCTION COOKTOPS, RICE COOKERS, AIR FRYERS), WHICH ARE EXPECTED TO BE THE PRIMARY GROWTH ENGINE, SUPPORTED BY A 4X SURGE IN AVERAGE WEEKLY INDUCTION COOKTOP SALES ON E-COMMERCE PLATFORMS. - BL

INDIA ROAD AND TRANSPORT MINISTER GADKARI PITCHES FOR FLEX FUEL VEHICLES UP TO E100 TO CURB OIL IMPORTS. ( BALRAMPUR CHINI, TRIVENI ENGINEERING, DALMIA BHARAT SUGAR

PNB HOUSING FINANCE: CO MD SAYS CO TARGETS 18-20% GROWTH IN FY27.

INFRA INVESTMENTS TO GROW 50% THROUGH FY28 DESPITE WEST ASIA CRISIS: CRISIL

MINES DEPARTMENT TARGETS 39% REVENUE GROWTH IN FY27;STATE MINES DEPARTMENT HAS SET A REVENUE TARGET OF AROUND ₹14,000 CRORE FOR THE CURRENT FINANCIAL YEAR- BS (NMDC, COAL INDIA, VEDANTA)

ACME SOLAR: CO HAS ACHIEVED MAJOR MILESTONE OF CUMULATIVELY OPERATIONALISING 2 GWH BESS CAPACITY IN RAJASTHAN, OVERALL, THE CO PLANS TO OPERATIONALISE 10 GWH OF BESS BY 2027.

RELIANCE INFRA: RUPEES 670 CR ASSET ATTACHMENT CONFIRMED UNDER PMLA, CO TO CHALLENGE ORDER

CRISIL: CO RECEIVES RUPEES 148.99 CRORE TAX DEMAND FOR AY23; TO CHALLENGE ASSESSMENT ORDER

AjantaPharma: US FDA concludes inspection at co’s mfg facility at Paithan, in Maharashtra Inspection conducted from April 13-21, issued Form-483 with 5 observations